Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 20 for “"Win 55,212-2"”.
-
Effetto nell’auto-somministrazione dell’agonista sintetico del recettore cannabinoide CB1, WIN 55,212-2, nel modello animale di depressione della bulbectomia olfattoria (OBX)
… intake of the cannabinoid CB1 receptor agonist WIN 55,212-2 (WIN, 12.5 μg/kg/infusion). The olfactory-bulbectomized rat is a well-established model that exhibits a high degree of behavioural and neurochemical similarity to depression. Male Lister Hooded rats were either olfactory-bulbectomized …
-
Ο ρόλος των CB1 υποδοχέων των κανναβινοειδών στις νευροβιολογικές δράσεις εξαρτησιογόνων φαρμάκων
… reward-related regions of the rat brain following administration of the cannabinoid CB1 agonists, Δ9-THC and WIN 55,212-2 as well as the effects of coadministration of WIN 55,212-2 and the CB1 antagonist, SR141716A on in vivo extracellular dopamine concentrations. In addition, the dopaminergic …
-
Functional Interactions Between the Cannabinoid System and Memory Consolidation in the Hippocampus: A Synthesis of Findings from Behavior, Morphology, Physiology, and Synaptic Signaling in the Rat
… modulation of synaptic transmission. In the following study the effects of a potent cannabinoid agonist, WIN 55,212-2, on rodent learning and memory in the dentate gyrus were examined using a combination of morphological, behavioral, electrophysiological, and gene targeting approaches. The current …
-
Ο ρόλος των CB1 υποδοχέων των κανναβινοειδών στις νευροβιολογικές δράσεις εξαρτησιογόνων φαρμάκων: Προεκτάσεις στη θεραπευτική
… molecular effects of cannabinoids (Δ⁹-THC and WIN 55,212-2) in two phenotypes of rats which were distinguished on the basis of their vertical activity upon exposure to a novel environment as high responders (HR) and low responders (LR). The studied cannabinoids influenced motor activity in a …
-
Comparison of tolerance characteristics in the guinea pig following chronic in-vivo exposure to opioid versus cannabinoid receptor agonists
… the nature of tolerance that develops following chronic in vivo opioid treatment with that which develops after chronic cannabinoid exposure in the same tissue and species. Based on similarities in signaling and overlapping neuroanatomical receptor localization the candidate determined …
-
Ο ρόλος του ενδογενούς συστήματος των κανναβινοειδών σε συμπεριφορικές και νευροβιολογικές παραμέτρους που σχετίζονται με τις γνωστικές λειτουργίες: πειραματική μελέτη σε επίμυες
… behavioural and neurochemical changesfollowing cannabinoid administration. In particular, the interactionsbetween agonists of CB1 receptors and processes of memory andlearning, as well as with the glutamatergic system, were investigated,The synthetic cannabinoid WIN 55-212,2 and also …
-
AN EXTENSION OF PLANARIAN BEHAVIORAL MODEL: CANNABINOID PHYSICAL DEPENDENCE AND WITHDRAWAL
… to the cannabinoid receptor (CB-R) agonist WIN 55,212-2 (10 μmol/L) for 1 h displayed a significant (p < 0.05) decrease in spontaneous locomotor velocity (pLMV) when subsequently tested in drug-free, but not in drug-containing, water. This demonstrated abstinence-induced withdrawal from a …
-
Modulation of limbic noradrenergic circuits by cannabinoids
… modulate mood, cognition and memory. There is growing evidence suggesting that cannabinoids can interact with the noradrenergic system. Noradrenergic transmission in the CNS has also been implicated in the regulation of mood, cognition and memory. In the present work, the hypothesis that …
-
Estudo sobre a participação dos receptores canabinóides hipocampais na retenção da memória de reconhecimento
… o treino, o agonista canabinóide não seletivo WIN-55,212-2, e o inibidor da recaptação celular de endocanabinóides VDM-11, impediram a retenção da memória de longa duração de reconhecimento de maneira dose-dependente sem, no entanto, afetar a memória de curta duração, a atividade exploratória e …
-
Hypothermie zur Neuroprotektion nach hypoxisch-ischämischer Schädigung durch Regulation des Kälteschockproteins RBM3
… Zusätzlich sollen die Wirkstoffe DADLE und WIN‑55,212‑2 auf ihre neuroprotektiven und synergistischen Effekte mit TH getestet werden. Methoden: Die neuronalen HT‑22 und mikroglialen BV‑2 Zellen wurden in eine direkte Co‑Kultur gebracht. Eine Oxygen-Glukose-Deprivation (OGD) und simulierte …
-
The human cannabinoid CB(1) receptor stably expressed in Chinese hamster ovary cells provides a model system to predict the pharmacological effects of cannabinoids in man
… binding studies using [³H]SR141716A and [³H]CP55,940 determined that this system expresses the human cannabinoid CB₁ receptor at approximately 1.8 pmoles of receptor/mg protein and that this expression system is able to differentially bind agonists (CP55,940) and antagonists (SR141716A). In the …
-
Studies on transient receptor potential vanilloid subtype 1 (TRPV1)-mediated degeneration of mesencephalic cellsin vivo and in vitro
… cultures with CB1 receptor agonists HU210 or WIN 55,212-2 also produced degeneration of DA neurons and increases in [Ca2+]i, which were inhibited by CZP, AM251 or BAPTA/AM. The CAP-, AEA-, HU210-, or WIN 55,212-2-induced increases in [Ca2+]i were dependent on extracellular Ca2+, with …
-
Characterization of functional expression of cannabinoid receptor 1 and transient receptor potential vanilloid 1 channel in human corneal endothelial cells
… capsazepine (CPZ) (10 µM). The CB1 agonist WIN 55,212-2 (10 µM), increased [Ca2+]i and whole-cell currents, which could be blocked with the CB1 antagonist AM251 (10 µM). The CAP (10 µM) induced Ca2+ rise was inhibited below the Ca2+ baseline if the HCEC-12 cells were preincubated with 10 µM …
-
Discriminative stimulus properties of 3-substituent rimonabant analogs
… to rimonabant, cocaine or morphine, whereas WIN 55,212-2 and nicotine evoked partial substitution. These results suggest that these analogs might exert their pharmacological properties through a novel cannabinoid receptor, as has been proposed for WIN 55,212-2 and anandamide. Additionally, …
-
Ο ρόλος του ενδογενούς συστήματος των κανναβινοειδών στη συμπεριφορά και στους μηχανισμούς ανταμοιβής: πειραματική μελέτη σε επιμύες
… efficacy of the self-stimulation in low doses (WIN 55,212-2, CP 55,940 and HU-210), while high doses have an inhibitory effect on reward and either do not affect or decrease the asymptotic rate of responding. Their effect is also probably mediated through CB1 receptor stimulation. Additionally, …
-
Changes in zebra finch central nervous system morphology associated with developmental cannabinoid exposure
… changes in synaptic connectivity. Growing evidence suggests that adolescent cannabis use is a risk factor for the development of persistent alterations in brain function. Taeniopygia guttata, the zebra finch, was used as a model of cannabinoid-altered vocal learning. We explored …
-
Role of the Cannabinoid System in Modulating the Reinforcing and Relapse Related Properties of Nicotine in Rats
… of pretreatment with the CB receptor agonist WIN 55, 212-2 (0.1-1mg/kg), on nicotine self-administration and on the reinstatement of nicotine seeking behaviour. In the next series of experiments, we used a selective CB1 inverse agonist rimonabant (0.3mg/kg) and CB2 antagonist AM630 (5mg/kg) to …
-
Relationship Between CB1 and S1P Receptors in the Central Nervous System
… binding using the synthetic cannabinoid agonist WIN 55,212-2 (WIN) or SIP. High levels of WIN- and S1P-stimulated [35S]GTPγS binding were observed in the caudate putamen, hippocampus, substantia nigra, and cerebellum. To further characterize the relationship between S1P-and CB1-mediated G-protein …
-
Kardioprotektion durch therapeutische Hypothermie und pharmakologische Intervention während simulierter Ischämie
… Leu5] Enkephalin = DADLE) und einem Cannabinoid (WIN-55,212-2 = WIN) behandelt und deren Wirkung auf die Kardiomyozyten untersucht. Die Ergebnisse wurden mit denen des ersten Teils verglichen. Dabei wurde auch ein möglicher synergistischer Effekt der Kombination von pharmakologischer Therapie und …
-
Uso de cannabinoides para el tratamiento de hemopatías malignas
… aguda (LMA). Demostramos que el cannabinoide WIN-55,212-2 (WIN-55) induce la apoptosis selectiva en líneas celulares de MM y en células plasmáticas primarias de pacientes con MM, a la vez que no afecta a las células normales de donantes sanos. Este efecto estuvo mediado por la activación de …